ABSTRACT
Background: Diabetes mellitus (DM) can be defined as chronic hyperglycemia due to lack in insulin secretion and/or action. This study was designed to compare the antidiabetic activity of Coriandrum sativum L. with the standard antidiabetic drug, Metformin in Streptozotocin induced diabetic rats.Methods: Streptozotocin (STZ) was used to induce diabetes in the rats. Standard drug was metformin and test drug were Coriandrum sativum seed extract. 4 groups of 8 rats each were taken (normal control, diabetic control, streptozotocin + Coriandrum sativum and streptozotocin + metformin). Blood Sugar Levels (BSL) and HbA1C levels were estimated on day 0, 14 and 28 and day 28 respectively.Results: Streptozotocin administration resulted in significant rise in BSL. This rise was reduced with the administration of CS seed extract, but the reduction was more with chronic administration. It also reduced the HbA1C levels but couldn’t attain total normoglycemia. However, the reduction of BSL was superior with Metformin compared to the test drug.Conclusions: Oral administration of Coriandrum sativum seed extract at a dose of 40 mg/kg has shown antihyperglycemic activity in streptozotocin induced diabetic rats. Thus, Coriandrum sativum may have considerable therapeutic benefit as an antidiabetic agent and can be suggested as a potential dietary add on.
ABSTRACT
Background: Dyslipidaemias are the major cause of increased atherogenesis. Lycopene is a pigment that imparts red colour to fruits and vegetables like tomatoes. Risk of cardiovascular diseases has been shown to decrease with dietary intake of tomatoes. Although the antioxidant and hypolipidaemic properties of tomatoes have been studied extensively, beneficial effect of pure lycopene supplement as hypolipidaemic is still debatable So, we aimed to evaluate the effect of pure lycopene powder on lipid profile, serum antioxidant enzymes and blood sugar level in hyperlipidaemic rabbits.Methods: Adult male New Zealand White rabbits (1.5-2.5kg) were divided into three groups of six each. Group I-High Fat Diet (HFD) (5ml/kg). Group II-HFD (5ml/kg) + lycopene (10mg/kg) orally. Group III-HFD (5ml/kg) + lycopene (20mg/kg) orally. Blood samples were taken from all rabbits for baseline estimations of serum lipids, serum superoxide dismutase (SOD) and blood sugar. Same tests were performed after six weeks.Results: There was significant decrease in the levels of serum TC, LDL-C, TG and VLDL and an increase in serum HDL-C and antioxidant SOD with lycopene administration. However, significant increase in HDL was not seen with lycopene 10mg. TG and VLDL levels were significantly less with 20mg lycopene compared to 10mg lycopene. There was however no change in blood sugar level with lycopene.Conclusions: Pure lycopene supplement showed significant hypolipidaemic and antioxidant activity. However, it did not show significant effect on blood glucose levels.
ABSTRACT
Introduction: In clinical practice, nonspecific antidiarrhealsare most commonly used by clinicians along with routinetreatment to hasten the recovery. This study was conductedto to study the safety and tolerability of these nonspecificantidiarrheals in children with acute diarrhea.Material and Methods: This was a prospective, observationalstudy done in clinical settings for a period of 3 years at twopediatric clinics and at a tertiary care hospital. Children weredivided into 5 treatment groups (viz, control, racecadotril,Mebarid, Diarex and loperamide) at the discretion of thepediatrician. One questionnaire was provided to parents torecord the details about the course of diarrhea and parentswere sensitized to report any adverse event.Results: Overall occurrence of adverse events wassignificantly higher in racecadotril group (34.86%) comparedto other groups (C:23.16%, M:21.14%, D:17.95%, L:17.65%).Conclusion: These agents may be safe, effective andinexpensive addition to the routine treatment of acute diarrhea.